Proclara Biosciences

Proclara is a clinical-stage biotechnology company pioneering breakthrough approaches for treating neurodegenerative and peripheral protein misfolding diseases. By developing novel therapies that identify and target multiple misfolded proteins, our goal is to make a transformative impact on the lives of patients affected by Alzheimer's, Parkinson's, and systemic amyloidosis. Our approach is shaped by an experienced team with deep drug development expertise and productive collaborations with world-class advisors and partners.